Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/13/07 → 6/30/10 |
A Randomized, Multicenter, Two-arm, Open Label, 12 Week Phase IIIB Study to Evaluate the Tolerability of Rebif (IFN Beta-LA) and Betaseron (IFN Beta-1B) in IFN-Naive Subjects with Relapsing Remitting Multiple Sclerosis; Followed by a Single-Arm 24
- Houff, Sidney (PI)